Friedl-Naderer Johanna
SEC insider (Form 3/4/5 filer). CIK 0001915598. Chief Commercial Officer at Dyne Therapeutics, Inc. (DYN). 15 reported Form 4/5 transactions since Sep 2024; latest on Sep 8, 2026. Located in WALTHAM, MA.
Companies Friedl-Naderer Johanna has filed insider reports for
- Dyne Therapeutics, Inc. (DYN): Officer, Chief Commercial Officer
Friedl-Naderer Johanna
CIK: 0001915598
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Dyne Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Sep 8, 2026DYN
Dyne Therapeutics, Inc.
SaleDirect185 shares at avg. $18.88$3K - Sep 4, 2026DYN
Dyne Therapeutics, Inc.
SaleDirect900 shares at avg. $24.35$22K - Aug 13, 2026DYN
Dyne Therapeutics, Inc.
SaleDirect226 shares at avg. $26.28$6K - Jun 16, 2026DYN
Dyne Therapeutics, Inc.
SaleDirect145 shares at avg. $18.33$3K - May 13, 2026DYN
Dyne Therapeutics, Inc.
SaleDirect228 shares at avg. $18.36$4K - Mar 5, 2026DYN
Dyne Therapeutics, Inc.
SaleDirect148 shares at avg. $14.90$2K - Feb 12, 2026DYN
Dyne Therapeutics, Inc.
AwardDirect60K shares- - Dec 5, 2025DYN
Dyne Therapeutics, Inc.
SaleDirect144 shares at avg. $20.72$3K - Sep 5, 2025DYN
Dyne Therapeutics, Inc.
SaleDirect144 shares at avg. $13.41$2K - Sep 4, 2025DYN
Dyne Therapeutics, Inc.
SaleDirect894 shares at avg. $13.27$12K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 8, 2026 | DYN Dyne Therapeutics, Inc. | Sale | 185 | $18.88 | $3,493 | Direct |
| Sep 4, 2026 | DYN Dyne Therapeutics, Inc. | Sale | 900 | $24.35 | $21,915 | Direct |
| Aug 13, 2026 | DYN Dyne Therapeutics, Inc. | Sale | 226 | $26.28 | $5,939 | Direct |
| Jun 16, 2026 | DYN Dyne Therapeutics, Inc. | Sale | 145 | $18.33 | $2,658 | Direct |
| May 13, 2026 | DYN Dyne Therapeutics, Inc. | Sale | 228 | $18.36 | $4,186 | Direct |
| Mar 5, 2026 | DYN Dyne Therapeutics, Inc. | Sale | 148 | $14.90 | $2,205 | Direct |
| Feb 12, 2026 | DYN Dyne Therapeutics, Inc. | Award | 60,000 | - | $0 | Direct |
| Dec 5, 2025 | DYN Dyne Therapeutics, Inc. | Sale | 144 | $20.72 | $2,984 | Direct |
| Sep 5, 2025 | DYN Dyne Therapeutics, Inc. | Sale | 144 | $13.41 | $1,931 | Direct |
| Sep 4, 2025 | DYN Dyne Therapeutics, Inc. | Sale | 894 | $13.27 | $11,863 | Direct |
1-10 of 15 transactions